TCF7L2 is a transcription factor in the Wnt signaling pathway and the strongest known genetic risk factor for type 2 diabetes (especially rs7903146). Its role in weight loss is indirect: risk allele carriers often have reduced insulin secretion and higher diabetes risk, but not necessarily different weight loss outcomes. Studies show lifestyle interventions (diet, exercise) are similarly effective in risk carriers. There is no direct evidence that TCF7L2 affects calorie expenditure or fat oxidation. Based on the provided context, MyBody-X does not test TCF7L2; their panel includes SIRT1, FADS1, etc. For weight management, blood tests (fasting insulin, glucose) and dietary counseling are more actionable than a single gene. Evidence: strong GWAS for diabetes, moderate for weight loss. Caveat: avoid overinterpreting a single SNP.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-f370867cb9cf937a05a7c336